Spots Global Cancer Trial Database for A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
Official Title: A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
Study ID: NCT02289261
Conditions
Study Description
Brief Summary: The purpose of this study is to determine whether dexmedetomidine added to morphine is effective in the treatment of chronic cancer pain.
Detailed Description: We conduct the study in Cukurova University Faculty of Medicine Research Hospital after obtaining ethics committee approval and patient's informed consent. Patients with cancer pain are allocated into two group to receive Patient Controlled Analgesia with morphine or morphine plus dexmedetomidine.
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cukurova University Faculty of Medicine Research Hospital, Adana, , Turkey
Contact Details
Name: Selcuk Gök, M.D
Affiliation: Cukurova University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
